MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$755,859K Accounts receivable, net$130,834K Inventory$34,930K Prepaid expenses andother current assets$18,767K Gross carrying value$240,212K Total current assets$940,390K License and acquiredintangibles, net$121,971K Deferred tax assets, net$55,111K Investment in equitysecurities$27,286K Operating leaseright-of-use asset, net$1,858K Property and equipment,net$994K Accumulated amortization$118,241K Total assets$1,147,610K Total liabilities andstockholders' equity$1,147,610K Total stockholders'equity$1,012,697K Total liabilities$134,913K Retained earnings$523,349K Additional paid-in capital$489,218K Common stock, 0.001 parvalue, 200,000,000...$122K Accumulated othercomprehensive income (loss)...$8K Total currentliabilities$132,398K Operating leaseliability, net of current...$2,235K Other non-currentliabilities$280K Accrued expenses andother liabilities$125,247K Accounts payable$7,151K
Balance Sheet

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)

source: myfinsight.com